Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.74
-0.42-3.19%
Enanta Pharmaceuticals Inc
ENTANASDAQ
Earnings: Q3 2026 Earnings were released on Mon Aug 10th, after the market close
Enanta Pharma Market Sentiment
Market sentiment signals for Enanta Pharma (ENTA): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 10.7% short float
Options Flow— N/A
Insider Activity— N/A
Analyst Consensus
Buy
10 analysts
Options Flow (P/C)
—
Avg Consensus PT
$19
+46.0%
Highest Price Target
$28
+119.8%
WestPark Capital
Lowest Price Target
$10
-21.5%
JP Morgan
Short Interest
10.7%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | HC Wainwright & Co. | Brandon Folkes— | +57.0% | $20 → $20 | Maintained | Buy |
| Feb 10, 2026 | HC Wainwright & Co. | Brandon Folkes— | +57.0% | $20 → $20 | Maintained | Buy |
